Where pharma’s performance is built by patient value  The world’s greatest gathering of pharma’s value-designers Every important industry player in one room, evolving our antiquated model by embracing value-based care. […]

CAR-T therapy is set to revolutionize oncology pipelines and mark a new era for personalized medicine. With the recent approvals of Yescarta and Kymriah and the $11 billion acquisition of […]

Built with thought-leaders at Sanofi, Eisai, AbbVie and Denali, the inaugural NIDD Summit will share the field’s cutting-edge scientific advances enabling you to translate your neuroimmunology research into a clinically effective therapeutic for neurological diseases. With an […]